|drug2183||Nicotinamide riboside Wiki||0.71|
|D003141||Communicable Diseases NIH||0.05|
|D045169||Severe Acute Respiratory Syndrome NIH||0.03|
There are 2 clinical trials
The outbreak of a new Coronavirus disease (COVID-19), caused by the 2019-nCoV infection in December 2019 is one of the most severe global epidemic health problems.The rapid contagion of this Novel virus has provoked the World Health Organization (WHO) to classifying the outbreak as a "Public Health Emergency of International Concern" on January 30 2020 to a "Pandemic" on March 11th 2020
Description: The diagnosis will be made based on the score resultsMeasure: The percentage of study participants diagnosed with sexual dysfunction Time: one month
The present study aims to assess the impact of exercise training, physical activity, and sedentary lifestyle on clinical outcomes in surviving patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, this study will evaluate cross-sectionally and through a questionnaire in Portuguese and English on the internet, whether physically active patients have better outcomes for the disease such as shorter hospital stay, lesser symptoms, lesser need for mechanical ventilation, and medications.
Description: Number of hospitalizations required due to COVID-19Measure: Number of hospitalizations Time: Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)
Description: Symptoms such as fever, cough, shortness of breathe, and muscle pain due to COVID-19Measure: Percentage of symptoms of the disease Time: Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)
Description: Length of hospital stay required due to COVID-19Measure: Length of hospital stay Time: Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)
Description: Need for mechanical ventilation during hospitalization due to COVID-19Measure: Percentage of mechanical ventilation Time: Up to 6 months after hospital discharge and/or full recovery from the disease (asymptomatic)
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports